Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32
Published . Updated .
The average one-year price target for Definium Therapeutics (NASDAQGS:DFTX) (DB:MMQ0) has been revised to $73.32 / share. This is an increase of 12.21% from the prior estimate of $65.34 dated September 11, 2026. These figures represent an aggregate of analyst targets and do not c
Directly affected
- DFTX Definium Therapeutics
Named in this report.
Indirectly affected
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDE ISHARES LIFEPATH TARGET DATE 2045 ETF USD
GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The average one-year price target for Definium Therapeutics (NASDAQGS:DFTX) (DB:MMQ0) has been revised to $73.32 / share. This is an increase of 12.21% from the prior estimate of $65.34 dated September 11, 2026. These figures represent an…
Source: Nasdaq Markets
Definium Therapeutics (DFTX) since this story, compared with the market
Since the first closing price after “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32,” Definium Therapeutics (DFTX) is -9.08%. The S&P 500 fund (SPY) is -1.08% over the same days, a -8.00% difference versus the market.
Who gains and who loses around Definium Therapeutics (DFTX)
Companies tied to this story
- DFTX Definium Therapeutics
For “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32,” Definium Therapeutics (DFTX) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names DEFINIUM THERAPEUTICS INC in the headline; GA resolved that company to DFTX
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
For “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32,” T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence. Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DOGG Ft Vest Djia Dogs 10 Target Income Etf
In “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32,” Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence. Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FGSI Ft Vest Growth Strength & Target Income Etf
For “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32,” Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence. Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDB Ishares Lifepath Target Date 2030 Etf
In “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32,” Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDC Ishares Lifepath Target Date 2035 Etf Usd
Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32.” Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDE Ishares Lifepath Target Date 2045 Etf Usd
Ishares Lifepath Target Date 2045 Etf Usd (ITDE) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32.” Reason on file: GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Definium Therapeutics (DFTX)
“Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32” (2 Oct 2026) reaches Definium Therapeutics (DFTX) through this story.
Definium Therapeutics (DFTX) is on the page because The reported development directly names DEFINIUM THERAPEUTICS INC in the headline; GA resolved that company to DFTX
T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is here too. Its reason reads: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Definium Therapeutics (DFTX), and the dates in the story
BTCZ traded between 2.69 and 3.21 across 20 sessions. The latest close on file is 3.06. DFTX traded between 32.02 and 40.39 across 20 sessions. The latest close on file is 32.96. DOGG traded between 20.68 and 22.21 across 20 sessions. The latest close on file is 21.99.
A simple score for Definium Therapeutics (DFTX)
46 out of 100
“Definium Therapeutics Consensus Price Target Raised 12.21% to $73.32” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.